Meghana Shah, partner, Eversheds Sutherland: I’ll be keeping my eye on CBD. The industry is experiencing exponential growth and crying out for federal regulatory clarity. With the recent introduction of the CBD Product Safety and Standardization Act in Congress, I expect, at the very least, increased dialogue around the optimal framework for federal CBD regulation in 2022.
‘There is still a lot of unresponsiveness or vague statements…’ Supply chain woes add to compliance challenge with bioengineered food disclosure standard
Cultivated meat, cell-cultured meat, lab-grown meat? Stakeholders weigh in on nomenclature as products near commercialization in US market
HempRise gears up to open $80m hemp processing facility in Indiana
‘The era of CBD prohibition in the Golden State is over...’ CA governor signs hemp bill AB 45 into law
